Unified Patent Court (UPC) analytics are now available. Check here

EP3110449

BOEHRINGER INGELHEIM
Application Number
EP15707338A
Filing Date
Feb 27, 2015
Status
Revoked
Jan 10, 2025
Grant Date
Jun 28, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3110449B1 was granted on Jun 28, 2023 by Boehringer Ingelheim The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMar 28, 2024ADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBBMar 26, 2024ADMISSIBLE
ZAKLADY FARMACEUTYCZNE POLPHARMAMar 26, 2024ADMISSIBLE
TEVA PHARMACEUTICAL INDUSTRIESMar 21, 2024ADMISSIBLE
SANDOZMar 13, 2024ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP3110449B1
N/A
OppositionWO2004018468
N/A
OppositionWO2005049022
N/A
OppositionWO2007128761
N/A
OppositionWO2010092124
N/A
OppositionWO2012065993
N/A
OppositionUS2012121530
N/A
OppositionWO2015128453
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.